cell therapy

Roche and SQZ expand cell therapy deal to more than $1.3bn

https://pharmaphorum.com/news/roche-and-sqz-expand-cell-therapy-deal-to-more-than-1-3bn/

Gilead signs biotech deal arming T-cells to attack solid tumours

https://pharmaphorum.com/news/gilead-signs-biotech-deal-arming-t-cells-to-attack-solid-tumours/

From Manufacturing to Patient Access: SMi’s Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/from-manufacturing-to-patient-access-smis-cell-gene-therapy-2018/

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/explore-the-latest-developments-in-atmps-at-cell-gene-therapy-2018-2/

Kite expands manufacturing capacity for CAR-T therapies

https://pharmaphorum.com/news/kite-expands-manufacturing-capacity-for-car-t-therapies/

Cell & Gene Therapy 2018

https://pharmaphorum.com/events/cell-gene-therapy-2018/

Natural killer cells ‘a hundred times cheaper’ than CAR-T

https://pharmaphorum.com/news/natural-killer-cancer-therapy-a-hundred-times-cheaper-than-car-t/

CAR:T – Has biology outpaced the ability to deliver?

https://pharmaphorum.com/partner-content-oncology/cart-biology-outpaced-ability-deliver/

CAR-T Congress USA | 20 – 22 March 2018 | Boston

https://pharmaphorum.com/events/car-t-congress-usa-20-22-march-2018-boston/

1 2

Close in 10 seconds

Pharmaphorum.com

Search